Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease

MLA

Xavier Guitart, et al. “Equilibrative Nucleoside Transporter ENT1 as a Biomarker of Huntington Disease.” Neurobiology of Disease, vol. 96, no. 47–53, Dec. 2016, pp. 47–53. EBSCOhost, https://doi.org/10.1016/j.nbd.2016.08.013.

APA

Xavier Guitart, Jordi Bonaventura, William Rea, Marco Orrú, Lucrezia Cellai, Ilaria Dettori, Felicita Pedata, Marc Brugarolas, Antonio Cortés, Vicent Casadó, Ching-Pang Chang, Manikandan Narayanan, Yijuang Chern, & Sergi Ferré. (2016). Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease. Neurobiology of Disease, 96(47–53), 47–53. https://doi.org/10.1016/j.nbd.2016.08.013

Chicago

Xavier Guitart, Jordi Bonaventura, William Rea, Marco Orrú, Lucrezia Cellai, Ilaria Dettori, Felicita Pedata, et al. 2016. “Equilibrative Nucleoside Transporter ENT1 as a Biomarker of Huntington Disease.” Neurobiology of Disease 96 (47–53): 47–53. doi:10.1016/j.nbd.2016.08.013.